Literature DB >> 24889386

Imported Plasmodium vivax malaria ex Pakistan.

Silvia Odolini1, Philippe Gautret, Kevin C Kain, Kitty Smith, Karin Leder, Mogens Jensenius, Christina M Coyle, Francesco Castelli, Alberto Matteelli.   

Abstract

BACKGROUND: According to WHO, 1.5 million cases of malaria are reported annually in Pakistan. Malaria distribution in Pakistan is heterogeneous, and some areas, including Punjab, are considered at low risk for malaria. The aim of this study is to describe the trend of imported malaria cases from Pakistan reported to the international surveillance systems from 2005 to 2012.
METHODS: Clinics reporting malaria cases acquired after a stay in Pakistan between January 1, 2005, and December 31, 2012, were identified from the GeoSentinel (http://www.geosentinel.org) and EuroTravNet (http://www.Eurotravnet.eu) networks. Demographic and travel-related information was retrieved from the database and further information such as areas of destination within Pakistan was obtained directly from the reporting sites. Standard linear regression models were used to assess the statistical significance of the time trend.
RESULTS: From January 2005 to December 2012, a total of 63 cases of malaria acquired in Pakistan were retrieved in six countries over three continents. A statistically significant increasing trend in imported Plasmodium vivax malaria cases acquired in Pakistan, particularly for those exposed in Punjab, was observed over time (p = 0.006).
CONCLUSIONS: Our observation may herald a variation in malaria incidence in the Punjab province of Pakistan. This is in contrast with the previously described decreasing incidence of malaria in travelers to the Indian subcontinent, and with reports that describe Punjab as a low risk area for malaria. Nevertheless, this event is considered plausible by international organizations. This has potential implications for changes in chemoprophylaxis options and reinforces the need for increased surveillance, also considering the risk of introduction of autochthonous P. vivax malaria in areas where competent vectors are present, such as Europe.
© 2014 International Society of Travel Medicine.

Entities:  

Mesh:

Year:  2014        PMID: 24889386     DOI: 10.1111/jtm.12134

Source DB:  PubMed          Journal:  J Travel Med        ISSN: 1195-1982            Impact factor:   8.490


  5 in total

1.  Epidemiology of Imported Malaria Cases in Japan, 2006-2014: A Sentinel Traveler Surveillance Approach.

Authors:  Atsuhiro Kanayama; Yuzo Arima; Tamano Matsui; Koki Kaku; Hitomi Kinoshita; Kazunori Oishi
Journal:  Am J Trop Med Hyg       Date:  2017-11       Impact factor: 2.345

2.  Effects of a malaria elimination program: a retrospective study of 623 cases from 2008 to 2013 in a Chinese county hospital near the China--Myanmar border.

Authors:  Xinyu Wang; Linlin Yang; Tao Jiang; Bingyan Zhang; Shuqing Wang; Xingfen Wu; Tianying Wang; Yanlin Li; Min Liu; Quanbang Peng; Wenhong Zhang
Journal:  Emerg Microbes Infect       Date:  2016-01-20       Impact factor: 7.163

3.  Clinical, geographical, and temporal risk factors associated with presentation and outcome of vivax malaria imported into the United Kingdom over 27 years: observational study.

Authors:  Claire Broderick; Behzad Nadjm; Valerie Smith; Marie Blaze; Anna Checkley; Peter L Chiodini; Christopher J M Whitty
Journal:  BMJ       Date:  2015-04-16

4.  Epidemiological and clinical assessment of a shared territorial malaria guideline in the 10 years of its implementation (Barcelona, North Metropolitan Area, Catalonia, Spain, 2007-2016).

Authors:  Josep M Mòdol; Sílvia Roure; Àlex Smithson; Gema Fernández-Rivas; Anna Esquerrà; Neus Robert; María Méndez; Javier Ramos; Anna Carreres; Lluís Valerio
Journal:  Malar J       Date:  2017-09-11       Impact factor: 2.979

5.  A decade of travel-associated malaria at King Fahad Hospital of the University in the Eastern Province of Saudi Arabia.

Authors:  Ashwaq Alanazi; Bayan Ahmad Hasan Almusailhi; Gheed K Bamousa; Nabaa H Alhawashim; Nourah M Alotaibi; Sumiyah AlShamekh; Basavaraja Channabasappa Hunasemarada; Reem Y Al Jindan; Ayman A El-Badry
Journal:  Sci Rep       Date:  2022-01-19       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.